Abzena PLC (ABZA) Stock Rating Reaffirmed by Numis Securities Ltd
Separately, FinnCap restated a buy rating and set a GBX 80 ($1.03) price target on shares of Abzena PLC in a research report on Wednesday, August 30th.
Shares of Abzena PLC (LON:ABZA) opened at 34.00 on Thursday. The company’s market cap is GBX 46.87 million. The firm’s 50-day moving average price is GBX 45.41 and its 200 day moving average price is GBX 41.25. Abzena PLC has a 52 week low of GBX 31.00 and a 52 week high of GBX 66.00.
Abzena PLC Company Profile
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Stock Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related stocks with our FREE daily email newsletter.